GLP-1s have taken the healthcare industry – and pop culture – by storm as an effective class of medication to help treat chronic obesity. The exploding popularity of GLP-1s for weight loss has created new challenges for employers and payers alike as they grapple with how to cover these pricey drugs. In this webinar, we'll discuss the history of GLP-1s in the midst of the rise of obesity and type-2 diabetes in the U.S., why a clinically-rigorous approach to diabetes prevention and care is so important, and the big picture of what GLP-1s mean for the business of treating diabetes and obesity.
In this webinar, you will learn:
- How employers can navigate GLP-1s as an effective medication for chronic obesity while considering strategies and program enhancements to deliver value and savings
- How a focus on a comprehensive, evidence-based behavior change program in conjunction with GLP-1 therapy can result in better outcomes and help manage cost growth
- What to take into consideration when evaluating your overall benefit philosophy regarding coverage of weight loss medications
